KCNN3 VARIANT AND RISK OF ATRIAL FIBRILLATION RECURRENCE AFTER CATHETER ABLATION  by Ueberham, Laura et al.
Arrhythmias
E613
JACC March 27, 2012
Volume 59, Issue 13
KCNN3 VARIANT AND RISK OF ATRIAL FIBRILLATION RECURRENCE AFTER CATHETER ABLATION
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Monday, March 26, 2012, 9:30 a.m.-10:30 a.m.
Session Title: Arrhythmias: AF/SVT: Outcomes after Catheter Ablation of Atrial Arrhythmias
Abstract Category: 16. Arrhythmias: AF/SVT
Presentation Number: 1237-184
Authors: Laura Ueberham, Andreas Bollmann, Arash Arya, Gerhard Hindricks, Volker Adams, Daniela Husser, Departments of Electrophysiology and 
Cardiology, Heart Center Leipzig, Leipzig, Germany
Background: Recent genome-wide association studies identified KCNN3 variants on chromosome 1q21 to confer risk for atrial fibrillation (AF). In 
this study, we tested the hypothesis that the chromosome 1q21 variant rs13376333 associates with AF recurrence after catheter ablation (CA).
Methods: 265 patients (70.2 % males, mean age 58.9 +/- 10.5 years) with paroxysmal (60.8 %) or persistent (39.2 %) AF who underwent CA were 
studied. Rs13376333 was genotyped using real-time polymerase chain reaction and fluorescence resonance energy transfer. AF recurrence was 
detected using serial 7-day Holter ECG recordings immediately, as well as 3, 6 and 12 months after CA.
Results: Early AF recurrence (ERAF) within the first week after CA was observed in 34.9 % and late AF recurrence (LRAF) between 3 and 12 months 
in 30.1 %. Minor allele frequency was 35.3 %. Using a dominant genetic model, variant carriers had a higher risk for ERAF (OR 1.720, 95 % CI: 1.012 
- 2.924, p=.044) but not LRAF. ERAF (OR 2.268, 95 % CI: 1.319 - 3.901, p=.003) and persistent AF (OR 1.797, 95 % CI: 1.056 - 3.057, p=.031) were 
associated with LRAF, with ERAF being the only independent predictor for LRAF.
Conclusions: The KCNN3 variant on chromosome 1q21 may modulate the risk for early but not late AF recurrence after catheter ablation. This 
finding points to different genetic pathways for AF recidivism in this setting.
